Luckie & Company Launches Healthcare Division
Marketing solutions agency Luckie announced the launch of "Luckie Health," a dedicated practice focused exclusively on solving business challenges for healthcare brands. Led by a group of former pharma marketing executives, Luckie Health will offer a business-first, data-centric approach to the challenges of healthcare marketing.
The practice is being led by Kamala Prince who spent 20+ years managing patient marketing and product launches at biotech and pharmaceutical companies including United Therapeutics, GlaxoSmithKline and ViiV Healthcare.
She is joined by Brian Lamkin, Luckie's SVP of analytics and integrated solutions, and former director of Rx analytics for Galderma.
John Petersen rounds out the leadership team as VP of healthcare solutions. Petersen joined Luckie in June 2022 after 30 years in consumer healthcare and pharmaceuticals, working with L'Oréal, Galderma, Novartis, AstraZeneca, and most recently as CCO of Crown Laboratories.
The group reports to Luckie CEO, John Gardner, who's managed marketing campaigns for Novartis, Eli Lily, Bayer Consumer Health, GSK, Merck and others.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
